Background This study aims to identify the status of continuous glucose monitoring (CGM) use among individuals with type 1 diabetes mellitus (T1DM) in South Korea and to investigate whether age-related disparities exist.
Methods Individuals with T1DM receiving intensive insulin therapy were identified from the Korean National Health Insurance Cohort (2019–2022). Characteristics of CGM users and non-users were compared, and the prescription rates of CGM and sensor- augmented pump (SAP) or automated insulin delivery (AID) systems according to age groups (<19, 19–39, 40–59, and ≥60 years) were analyzed using chi-square tests. Glycosylated hemoglobin (HbA1c) levels and coefficients of variation (CV) among CGM users were also examined.
Results Among the 56,908 individuals with T1DM, 10,822 (19.0%) used CGM at least once, and 6,073 (10.7%) used CGM continuously. Only 241 (0.4%) individuals utilized either SAP or AID systems. CGM users were younger than non-users. The continuous prescription rate of CGM was highest among individuals aged <19 years (37.0%), followed by those aged 19–39 years (15.8%), 40–59 years (10.7%), and ≥60 years (3.9%) (P<0.001 for between-group differences). Among CGM users, HbA1c levels decreased from 8.7%±2.4% at baseline to 7.2%±1.2% at 24 months, and CV decreased from 36.6%±11.9% at 3 months to 34.1%±12.7% at 24 months.
Conclusion Despite national reimbursement for CGM devices, the prescription rates of CGM remain low, particularly among older adults. Given the improvements in HbA1c and CV following CGM initiation, more efforts are needed to increase CGM utilization and reduce age-related disparities.
Citations
Citations to this article as recorded by
Efficacy and Safety of Stage 5 Connected Insulin Pens in Type 1 or Type 2 Diabetes: Randomized Controlled Trial Protocol (SMART-5 Study) Ji Yoon Kim, Nam Hoon Kim, Soo Heon Kwak, Chang Hee Jung, Eun Seok Kang, Jun Sung Moon, Sun Joon Moon, So Yoon Kwon, Jee Hee Yoo, Younghoon Kim, Tae-min Lee, Chung-il Yang, Jae Hyeon Kim, Sang-Man Jin Endocrinology and Metabolism.2026; 41(3): 393. CrossRef
Association of perceived diabetes stigma with time below range <3.0 mmol/L and anxiety in adults with type 1 diabetes using continuous glucose monitoring Seohyun Kim, Soojin Park, Sang‐Man Jin, Jae Hyeon Kim, Gyuri Kim Diabetic Medicine.2026;[Epub] CrossRef
Suboptimal adoption of diabetes technology despite coverage and the impact on glycemic outcomes in children and adolescents with type 1 diabetes in Hong Kong Sarah Wing-yiu Poon, Kwong-tat Chan, Betty Wai-man But, Shirley Man-yee Wong, Wing-in Yam, Pik-to Cheung, Wing-shan See, Suk-yan Chan, Ho-chung Yau, Eunice Wai Yu Wong, Lap Ming Wong, Antony Chun-cheung Fu, Elaine Yin-wah Kwan, Janez Heung-ching Tsui, Sin Journal of Pediatric Endocrinology and Metabolism.2026; 39(3): 251. CrossRef
Preliminary clinical outcomes and adoption of continuous glucose monitoring following reimbursement implementation in patients with type 1 diabetes in Thailand Nichapa Yordsudueam, Nattakarn Numsriskulrat, Worapimon Lerdrassameethad, Pattayarporn Paleekul, Jutipond jitchana, Nitchakarn Laichuthai, Taninee Sahakitrungruang Annals of Pediatric Endocrinology & Metabolism.2026; 31(1): 66. CrossRef
Challenges and Opportunities for Improving Care for Type 1 Diabetes in Older Adulthood Anna R. Kahkoska, Joshua J. Neumiller, Anastasia-Stefania Alexopoulos, Amlan Barik, Elbert S. Huang, Lori M. Laffel, Naushira Pandya, Christine Slyne, Elena Toschi, Ruth S. Weinstock, Medha Munshi Diabetes Care.2026; 49(4): 559. CrossRef
Continuous glucose monitoring and risks of acute and chronic diabetes-related complications and mortality in adults with type 1 diabetes: a nationwide cohort study Ji Yoon Kim, Seohyun Kim, Jae Hyeon Kim Diabetologia.2026; 69(7): 1858. CrossRef
Integrating Pharmacists into CGM-Enabled Digital Diabetes Care: Advancing Personalized and Data-Driven Management Xiaoxiao Chen, Gyeong Eon Kim, Nam Ah Kim, Kwang Joon Kim Healthcare.2026; 14(8): 1019. CrossRef
Temporal trends in treatment-requiring microvascular complications in young-onset diabetes: A nationwide population-based study Hwa Young Kim, Eunjeong Ji, Jaehyun Kim Diabetes Research and Clinical Practice.2026; 238: 113349. CrossRef
The National Health Insurance Support System for Diabetes Consumables and Management Devices in South Korea: Status, Challenges, and Policy Directions Okha Ryu, Yo Han Lee Health Insurance Review & Assessment Service Research.2026; 6(1): 46. CrossRef
High Waist-to-Height Ratio Increases the Risk of Cardiovascular Outcomes in Adults with Type 1 Diabetes Mellitus: A Nationwide Cohort Study Kyeong-Jin Kim, Seohyun Kim, Rosa Oh, So Hyun Cho, Myunghwa Jang, You-Bin Lee, Gyuri Kim, Sang-Man Jin, Kyu Yeon Hur, Ji Yoon Kim, Jae Hyeon Kim Diabetes & Metabolism Journal.2026; 50(4): 739. CrossRef
Trends of insulin pump therapy and continuous glucose monitoring use among people with type 1 diabetes by institution and region in Japan during 2014 and 2022: an observational study using nationwide claims data Takuya Yamaoka, Takehiro Sugiyama, Kimikazu Kashiwagi, Takashi Furuno, Kouko Yamamoto, Kenjiro Imai, Noriko Ihana-Sugiyama, Yuichi Nishioka, Mitsuru Ohsugi, Kohjiro Ueki, Akira Shimada, Toshimasa Yamauchi Diabetes Research and Clinical Practice.2026; 239: 113462. CrossRef
Retrospective Validation of a Stage 5 Decision Support Algorithm Using Clinical Trial Data From Stage 4 Smart Insulin Pens Jee Hee Yoo, Seohyun Kim, Younghoon Kim, Sang-Man Jin, Jae Hyeon Kim Journal of Diabetes Science and Technology.2026;[Epub] CrossRef
Utilization and Impact of Diabetes Technology among Type 1 Diabetes Patients at a Tertiary Hospital in Thailand Jirawan Pongrujikorn , Jutipond Jitchana, Nitchakarn Laichuthai Journal of the ASEAN Federation of Endocrine Societies.2026;[Epub] CrossRef
Sequential use of continuous glucose monitoring, with or without exercise trackers, significantly improves glycemic control in patients with type 2 diabetes Anushka Lahiri, Suan Tee Lim, Htike Kyu, Yock Young Dan, Chin Meng Khoo Diabetology & Metabolic Syndrome.2025;[Epub] CrossRef